Match your study stage
By stagePreclinical, first-in-human, pivotal, or post-approval — where your programme sits shapes which disciplines lead and how they combine.
Solutions Solutions shaped
Solutions shaped
around your study
Our service lines combine into solutions shaped around your programme — from embedded FSP teams to study rescues.
The practical application layer
of the business
Clinical Solutions
Biometric delivery for interventional trials, end to end.
Explore →Consulting
Strategic biostatistics and regulatory advice when you need a steer.
Explore →FSP
FSP, project-based, and hybrid — the engagement that fits.
Explore →RWE & Post-Approval Studies
NIS, registries, PASS/PAES, and comparative effectiveness studies.
Explore →Therapeutic Areas
30+ indications including a dedicated oncology practice.
Explore →Innovation & Automation
Metadata-driven pipelines and validated automation across biometrics.
Explore →Not Sure Which Solution Fits?
Let's scope it together. We'll help define the right model, capability mix, and delivery path based on your study needs.
Let's talk →Four lenses for choosing your solution path.
Choose a support model
By modelA fully scoped project, embedded FSP teams, or a hybrid — pick the engagement that fits how your team already works.
Lead with the evidence need
By evidenceThe decisions you need to defend — interim reads, submission datasets, real-world evidence — determine the capability mix.
Set your delivery priority
By prioritySpeed, alignment, or risk control — telling us what matters most lets us shape the right team and timeline around it.
Built for the team you actually have
The Challenge
Execution under pressure without infrastructure — limited in-house expertise, lean teams, budget pressure, and investor-driven timelines for a first pivotal study.
Our Solution
A trusted end-to-end partner. We take ownership of execution from protocol to submission — removing complexity and giving investors confidence, with a single senior point of contact.
The Challenge
Scaling without losing control — overstretched teams, maturing processes, vendor complexity, and a pipeline that needs to grow faster than headcount.
Our Solution
Flexible, scalable support. We adapt as you grow — blending project-based delivery with FSP embedded teams and surge capacity for ISS/ISE as the pipeline expands.
The Challenge
Complex, global operations — large vendor ecosystems, the need for standardisation, governance, and risk mitigation across many concurrent studies.
Our Solution
Strategic reliability. We plug into your enterprise framework — CDISC specialism, FSP biostatistics and programming, IDMC support — strengthening operations you already run.
By the numbers
A solutions track record across the pipeline.
800+ projects delivered
180+ phase II studies
120+ phase III studies
11 oncology indications
90+ phase IV studies
70+ medical device studies
„Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua, quis nostrud exercitation ullamco laboris nisi ut aliquip.”
Frequently asked
Choosing the right solution
What is the difference between Services and Solutions?
Services are the disciplines we deliver (biostatistics, CDM, programming, writing, non-clinical). Solutions are the shapes engagements take when those services combine for a particular need — a full FSP team, a rescue mission, a CDISC submission. Most sponsors think in terms of solutions first.
Can I combine multiple solutions?
Almost always. A typical engagement combines a delivery model (FSP or project) with a phase focus (drug development cycle), a therapeutic depth (a TA), and one or more horizontal capabilities (CDISC, rescue). One senior account lead coordinates across them.
How quickly can a solution be scoped?
Senior contact responds to RFIs within two business days. Initial scoping calls happen within the first week, with a tailored proposal typically inside three weeks for standard engagements.